{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T17:40:07Z","timestamp":1775670007521,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12889-017-4840-4","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T20:08:30Z","timestamp":1508875710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["High variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in Germany"],"prefix":"10.1186","volume":"17","author":[{"given":"Jana","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Kollan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviane","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,25]]},"reference":[{"issue":"3","key":"4840_CR1","first-page":"272","volume":"15","author":"NM Marques","year":"2011","unstructured":"Marques NM, et al. Seroepidemiological survey of transmissible infectious diseases in a portuguese prison establishment. Braz J Infect Dis. 2011;15(3):272\u20135.","journal-title":"Braz J Infect Dis"},{"issue":"2","key":"4840_CR2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1017\/S0950268806006820","volume":"135","author":"MF Meyer","year":"2007","unstructured":"Meyer MF, et al. Prevalence of hepatitis C in a German prison for young men in relation to country of birth. Epidemiol Infect. 2007;135(2):274\u201380.","journal-title":"Epidemiol Infect"},{"key":"4840_CR3","unstructured":"Radun, D., C. Weilandt, and O. Hamouda, Querschnittsstudie zur Pr\u00e4valenz von Hepatitis B, Hepatitis C, HIV und infektionsrelevantem Risikoverhalten unter Insassen ausgew\u00e4hlter Justizvollzugsanstalten in Deutschland in Verbindung mit einer Befragung von Justizbediensteten zu Wissen, Einstellungen, Risikobewu\u00dftsein und Verhalten zu Hepatitis B, Hepatitis C, HIV und Drogenkonsum. Abschlussbericht an das BMG 2007, Robert Koch-Institut, Wissenschaftliches Institut der \u00c4rzte in Deutschland (WIAD e.V.)."},{"issue":"3","key":"4840_CR4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1086\/341418","volume":"35","author":"KH Mayer","year":"2002","unstructured":"Mayer KH, et al. Human immunodeficiency virus in correctional facilities: a review. Clin Infect Dis. 2002;35(3):305\u201312.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4840_CR5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/17449200802692144","volume":"5","author":"B Schulte","year":"2009","unstructured":"Schulte B, et al. Substitution treatment and HCV\/HIV-infection in a sample of 31 German prisons for sentenced inmates. Int J Prison Health. 2009;5(1):39\u201344.","journal-title":"Int J Prison Health"},{"issue":"02","key":"4840_CR6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0032-1311600","volume":"13","author":"H St\u00f6ver","year":"2012","unstructured":"St\u00f6ver H. Drogenabh\u00e4ngige in Haft - Epidemiologie, Pr\u00e4vention und Behandlung in Totalen Institutionen. Suchttherapie. 2012;13(02):74\u201380.","journal-title":"Suchttherapie"},{"issue":"11","key":"4840_CR7","first-page":"1215","volume":"10","author":"A Aerts","year":"2006","unstructured":"Aerts A, et al. Tuberculosis and tuberculosis control in European prisons. Int J Tuberc Lung Dis. 2006;10(11):1215\u201323.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"4840_CR8","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1023\/A:1010833917242","volume":"16","author":"PB Christensen","year":"2000","unstructured":"Christensen PB, et al. Prevalence and incidence of bloodborne viral infections among Danish prisoners. Eur J Epidemiol. 2000;16(11):1043\u20139.","journal-title":"Eur J Epidemiol"},{"key":"4840_CR9","unstructured":"National Institute of Allergy and Infectious Diseases (NIAID). Tuberculosis (TB). 2016 [cited 2016 27 September 2016]; Available from: \nhttps:\/\/www.niaid.nih.gov\/diseases-conditions\/tuberculosis-tb\n\n."},{"key":"4840_CR10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1186\/1471-2458-10-633","volume":"10","author":"S Teutsch","year":"2010","unstructured":"Teutsch S, et al. Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort. BMC Public Health. 2010;10:633.","journal-title":"BMC Public Health"},{"issue":"6","key":"4840_CR11","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/ije\/26.6.1359","volume":"26","author":"K Stark","year":"1997","unstructured":"Stark K, et al. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol. 1997;26(6):1359\u201366.","journal-title":"Int J Epidemiol"},{"issue":"11","key":"4840_CR12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijid.2010.03.019","volume":"14","author":"S Jafari","year":"2010","unstructured":"Jafari S, et al. Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis. Int J Infect Dis. 2010;14(11):13.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"4840_CR13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajic.2009.06.006","volume":"38","author":"T Abiona","year":"2010","unstructured":"Abiona T, et al. Body art practices among inmates: implications for transmission of bloodborne infections. Am J Infect Control. 2010;38(2):121\u20139.","journal-title":"Am J Infect Control"},{"issue":"2","key":"4840_CR14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00103-009-1023-1","volume":"53","author":"K Keppler","year":"2010","unstructured":"Keppler K, et al. Prison health is public health! Problems in adapting and implementing health services for prisoners in Germany. Rev Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010;53(2):233\u201344.","journal-title":"Rev Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"2","key":"4840_CR15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1360-0443.2006.01316.x","volume":"101","author":"S Fazel","year":"2006","unstructured":"Fazel S, Bains P, Doll H. Substance abuse and dependence in prisoners: a systematic review. Addiction. 2006;101(2):181\u201391.","journal-title":"Addiction"},{"issue":"Suppl 6","key":"4840_CR16","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1186\/1471-2334-14-S6-S17","volume":"14","author":"A Arain","year":"2014","unstructured":"Arain A, Robaeys G, Stover H. Hepatitis C in European prisons: a call for an evidence-informed response. BMC Infect Dis. 2014;14(Suppl 6):S17.","journal-title":"BMC Infect Dis"},{"issue":"10049","key":"4840_CR17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0140-6736(16)30466-4","volume":"388","author":"K Dolan","year":"2016","unstructured":"Dolan K, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016;388(10049):1089\u2013102.","journal-title":"Lancet"},{"key":"4840_CR18","doi-asserted-by":"crossref","first-page":"f2216","DOI":"10.1136\/bmj.f2216","volume":"346","author":"S Ginn","year":"2013","unstructured":"Ginn S. Promoting health in prison. BMJ. 2013;346:f2216.","journal-title":"BMJ"},{"issue":"9769","key":"4840_CR19","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(10)61053-7","volume":"377","author":"S Fazel","year":"2011","unstructured":"Fazel S, Baillargeon J. The health of prisoners. Lancet. 2011;377(9769):956\u201365.","journal-title":"Lancet"},{"issue":"1","key":"4840_CR20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1473-3099(08)70305-0","volume":"9","author":"R J\u00fcrgens","year":"2009","unstructured":"J\u00fcrgens R, Ball A, Verster A. Interventions to reduce HIV transmission related to injecting drug use in prison. Lancet Infect Dis. 2009;9(1):57\u201366.","journal-title":"Lancet Infect Dis"},{"key":"4840_CR21","unstructured":"Kerr T, Juergens R. Syringe Exchange Programs in Prisons: Reviewing the Evidence. Canadian HIV\/AIDS Legal Network. 2004;1:1\u20137."},{"key":"4840_CR22","unstructured":"Knorr, B., Gesundheit und Pr\u00e4vention in Haft. Klee, J.; St\u00f6ver, H.: Drogen, HIV\/AIDS, Hepatitis. Ein Handbuch. Berlin, 2004."},{"issue":"3","key":"4840_CR23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1360-0443.2011.03676.x","volume":"107","author":"D Hedrich","year":"2012","unstructured":"Hedrich D, et al. The effectiveness of opioid maintenance treatment in prison settings: a systematic review. Addiction. 2012;107(3):501\u201317.","journal-title":"Addiction"},{"key":"4840_CR24","unstructured":"B\u00f6s, L., Die Tuberkulosesitation im Berliner Justizvollzug 2007\u20132010. Master thesis. Berlin: Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin School of Public Health; 2011."},{"key":"4840_CR25","unstructured":"Deutsche AIDS-Gesellschaft (DAIG), Deutsch-\u00d6sterreichische Leitlinien zur antiretroviralen Therapie der HIV-Infektion. 2012: 41."},{"issue":"3","key":"4840_CR26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0031-1291619","volume":"66","author":"T Schaberg","year":"2012","unstructured":"Schaberg T, et al. Recommendations for therapy, chemoprevention and chemoprophylaxis of tuberculosis in adults and children. German central committee against tuberculosis (DZK), German respiratory society (DGP). Pneumologie. 2012;66(3):133\u201371.","journal-title":"Pneumologie"},{"key":"4840_CR27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-0028-1110008","volume":"48","author":"C Sarrazin","year":"2010","unstructured":"Sarrazin C, et al. Update der S 3-Leitlinie Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-infektion. Z Gastroenterol. 2010;48:289\u2013351.","journal-title":"Z Gastroenterol"},{"issue":"1","key":"4840_CR28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-0031-1282015","volume":"50","author":"C Sarrazin","year":"2012","unstructured":"Sarrazin C, et al. Expertenempfehlungen zur Triple-Therapie der HCV-Infektion mit Boceprevir und Telaprevir. Z Gastroenterol. 2012;50(1):57\u201372.","journal-title":"Z Gastroenterol"},{"key":"4840_CR29","unstructured":"Backmund, M., et al., Leitlinien der Deutschen Gesellschaft f\u00fcr Suchtmedizin (DGS e.V.): Therapie der Opiatabh\u00e4ngigkeit \u2013 Teil 1: Substitutionsbehandlung. 2013."},{"issue":"10049","key":"4840_CR30","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S0140-6736(16)30830-3","volume":"388","author":"L Shrage","year":"2016","unstructured":"Shrage L. African Americans, HIV, and mass incarceration. Lancet. 2016;388(10049):e2\u20133.","journal-title":"Lancet"},{"key":"4840_CR31","unstructured":"Statistisches Bundesamt. Rechtspflege, Bestand der Gefangenen und Verwahrten in den deutschen Justizvollzugsanstalten nach ihrer Unterbringung auf Haftpl\u00e4tzen des geschlossenen und offenen Vollzugs jeweils zu den Stichtagen 31. M\u00e4rz, 31. August und 30. November eines Jahres. 2013."},{"key":"4840_CR32","unstructured":"Bundeszentrale f\u00fcr politische Bildung (bpb). F\u00f6deralismusreform. 2015; Available from: \nhttp:\/\/www.bpb.de\/nachschlagen\/lexika\/recht-a-z\/22184\/foederalismusreform\n\n."},{"key":"4840_CR33","volume-title":"Gef\u00e4ngnismedizin. Medizinische Versorgung unter Haftbedingungen","year":"2009","unstructured":"Keppler K, St\u00f6ver H, editors. Gef\u00e4ngnismedizin. Medizinische Versorgung unter Haftbedingungen. Stuttgart: Georg Thieme Verlag KG; 2009."},{"key":"4840_CR34","unstructured":"Deutsche AIDS-Hilfe e.V., Betreuung im_Strafvollzug. Ein Handbuch. 5. Auflage 2014, ed. 2014, Berlin."},{"issue":"1","key":"4840_CR35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1024\/0939-5911.a000228","volume":"59","author":"L Jakob","year":"2013","unstructured":"Jakob L, St\u00f6ver H, Pfeiffer-Gerschel T. Suchtbezogene Gesundheitsversorgung von Inhaftierten in Deutschland - eine Bestandsaufnahme. Sucht. 2013;59(1):39\u201350.","journal-title":"Sucht"},{"key":"4840_CR36","unstructured":"Ministerium der Justiz, Vollstreckungsplan f\u00fcr das Saarland. Germany: Ministry of Justice Saarland; 2011."},{"key":"4840_CR37","unstructured":"Ministerium f\u00fcr Justiz. Kultur und Europa, Vollstreckungsplan f\u00fcr das Land Schleswig-Holstein. 1998."},{"key":"4840_CR38","unstructured":"Th\u00fcringer Justizministerium, Th\u00fcringer Verordnung \u00fcber den Vollstreckungsplan. Germany: Ministry of Justice Thuringia; 2010."},{"key":"4840_CR39","unstructured":"Pfeiffer-Gerschel, T., et al., Bericht 2011 des nationalen REITOX-Knotenpunkts an die EBDD. Deutschland. Neue Entwicklungen, Trends und Hintergrundinformationen zu Schwerpunktthemen. Drogensituation, 2011. 2010."},{"key":"4840_CR40","doi-asserted-by":"publisher","unstructured":"Hirnschall G, Harries AD, Easterbrook PJ, Doherty MC, Ball A. The next generation of the World Health Organization's global antiretroviral guidance. J Int AIDS Soc. 2013;16(1):18757. Published online 2013 Jun 30. doi:\n10.7448\/IAS.16.1.18757\n\n. PMCID: PMC3699697.","DOI":"10.7448\/IAS.16.1.18757"},{"key":"4840_CR41","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12889-015-1598-4","volume":"15","author":"D Schmidt","year":"2015","unstructured":"Schmidt D, et al. From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany. BMC Public Health. 2015;15:252.","journal-title":"BMC Public Health"},{"key":"4840_CR42","unstructured":"St\u00f6ver, H., Substitutionsbehandlungen f\u00fcr Opioidabh\u00e4ngige im Justiz-und Ma\u00dfregelvollzug. Neue Wege in der Suchtbehandlung im Ma\u00dfregelvollzug, 2011."},{"key":"4840_CR43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-7517-4-5","volume":"4","author":"I Michels","year":"2007","unstructured":"Michels I, Stover H, Gerlach R. Substitution treatment for opioid addicts in Germany. Harm Reduct J. 2007;4:5.","journal-title":"Harm Reduct J"},{"key":"4840_CR44","unstructured":"Hauer, B., Die Tuberkulosesituation im Berliner Justizvollzug 1996\u20131998. Magisterarbeit. Berlin: Technische Universit\u00e4t Berlin, Institut f\u00fcr Gesundheitswissenschaften, Postgradualer Studiengang Public Health; 2001."},{"issue":"2014","key":"4840_CR45","first-page":"275","volume":"31","author":"Robert Koch-Institut (RKI)","year":"2014","unstructured":"Robert Koch-Institut (RKI). Zur Situation bei wichtigen Infektionskrankheiten in Deutschland: Virushepatitis C im Jahr 2013. Epidemiologisches Bulletin. 2014;31(2014):275\u201388.","journal-title":"Epidemiologisches Bulletin"},{"key":"4840_CR46","unstructured":"Lehmann, M., et al., Gesundheit in Haft. Handbuch f\u00fcr Justiz, Medizin, Psychologie und Sozialarbeit. Lengerich: Pabst Science Publishers; 2014."},{"issue":"1","key":"4840_CR47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jhep.2017.01.024","volume":"67","author":"R Zimmermann","year":"2017","unstructured":"Zimmermann R, et al. Real-world treatment for chronic hepatitis C infection in Germany: analyses from drug prescription data, 2010\u20132015. J Hepatol. 2017;67(1):15\u201322.","journal-title":"J Hepatol"},{"key":"4840_CR48","first-page":"25","volume":"9","author":"F Sch\u00e4ffler","year":"2012","unstructured":"Sch\u00e4ffler F, Zimmermann S. Drogenabh\u00e4ngigkeit in bayerischen Haftanstalten \u2013 Darstellung und Diskussion ausgew\u00e4hlter Ergebnisse einer bayernweiten Umfrage bei ehemals inhaftierten, drogenkonsumierenden Menschen (n = 195). Akzeptanzorientierte Drogenarbeit Acceptance-Oriented Drug Work. 2012;9:25\u201338.","journal-title":"Akzeptanzorientierte Drogenarbeit Acceptance-Oriented Drug Work"},{"issue":"Suppl 1","key":"4840_CR49","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.drugpo.2014.10.012","volume":"26","author":"K Dolan","year":"2015","unstructured":"Dolan K, et al. People who inject drugs in prison: HIV prevalence, transmission and prevention. Int J Drug Policy. 2015;26(Suppl 1):S12\u20135.","journal-title":"Int J Drug Policy"},{"issue":"10","key":"4840_CR50","doi-asserted-by":"crossref","first-page":"762","DOI":"10.7326\/0003-4819-144-10-200605160-00010","volume":"144","author":"AC Spaulding","year":"2006","unstructured":"Spaulding AC, et al. A framework for management of hepatitis C in prisons. Ann Intern Med. 2006;144(10):762\u20139.","journal-title":"Ann Intern Med"},{"issue":"21","key":"4840_CR51","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.4254\/wjh.v7.i21.2323","volume":"7","author":"R Zampino","year":"2015","unstructured":"Zampino R, et al. Hepatitis C virus infection and prisoners: epidemiology, outcome and treatment. World J Hepatol. 2015;7(21):2323\u201330.","journal-title":"World J Hepatol"},{"key":"4840_CR52","volume-title":"Effectiveness of interventions to address HIV in prisons. Evidence for action technical papers","author":"WHO","year":"2007","unstructured":"WHO, UNAIDS, UNODC. Effectiveness of interventions to address HIV in prisons. Evidence for action technical papers. Geneva: World Health Organization; 2007."},{"issue":"6","key":"4840_CR53","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1360-0443.2005.01050.x","volume":"100","author":"KA Dolan","year":"2005","unstructured":"Dolan KA, et al. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. Addiction. 2005;100(6):820\u20138.","journal-title":"Addiction"},{"key":"4840_CR54","unstructured":"Bundes\u00e4rztekammer, Richtlinien der Bundes\u00e4rztekammer zur Durchf\u00fchrung der substitutionsgest\u00fctzten Behandlung Opiatabh\u00e4ngiger. 2010."},{"key":"4840_CR55","unstructured":"Intert, F., personal communication 2014."},{"key":"4840_CR56","unstructured":"Peiffer, U., personal communication 2014."},{"key":"4840_CR57","unstructured":"World Health Organization (WHO), Good governance for prison health in the 21st century. A policy brief on the organization of prison health. Geneva: World Health Organization; 2013."},{"key":"4840_CR58","unstructured":"Fricke, U., et al., Anatomisch-therapeutisch-chemische Klassifikation mit \\Tagesdosen f\u00fcr den deutschen Arzneimittelmarkt. 2013, GKV-Arzneimittelindex im Wissenschaftlichen Institut der AOK (WIdO): Berlin. p. 288."},{"key":"4840_CR59","unstructured":"Fachinformation Pegasys\u00ae - Roche Pharma AG. 2016."},{"key":"4840_CR60","unstructured":"Fachinformation PegIntron\u00ae Clearclick\u00ae Fertigpen - MSD SHARP & DOHME GMBH. 2015."},{"key":"4840_CR61","first-page":"CD002208","volume":"3","author":"F Faggiano","year":"2003","unstructured":"Faggiano F, et al. Methadone maintenance at different dosages for opioid dependence (review). Cochrane Database Syst Rev. 2003;3:CD002208.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"4840_CR62","first-page":"1303","volume":"283","author":"KL Sees","year":"2000","unstructured":"Sees KL, et al. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of Opioid dependence. Randomized Controlled Trial JAMA. 2000;283(10):1303\u201310.","journal-title":"Randomized Controlled Trial JAMA"},{"issue":"11","key":"4840_CR63","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jama.281.11.1000","volume":"281","author":"EC Strain","year":"1999","unstructured":"Strain EC, et al. Moderate- vs high-DoseMethadone in the treatment of Opioid dependence a randomized trial. JAMA. 1999;281(11):1000\u20135.","journal-title":"JAMA"},{"key":"4840_CR64","unstructured":"Verster, A. and E. Buning, Richtlinien zur Methadonsubstitution. Euro-Methwork 2000."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-017-4840-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T20:09:04Z","timestamp":1508875744000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-017-4840-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,25]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["4840"],"URL":"https:\/\/doi.org\/10.1186\/s12889-017-4840-4","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,25]]},"article-number":"843"}}